Home/Filings/4/0001209191-20-001462
4//SEC Filing

Alafi Christopher D 4

Accession 0001209191-20-001462

CIK 0001567514other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 9:11 PM ET

Size

7.7 KB

Accession

0001209191-20-001462

Insider Transaction Report

Form 4
Period: 2019-12-31
Alafi Christopher D
Director10% Owner
Transactions
  • Award

    Common Stock

    2019-12-31$34.31/sh+422$14,479343,586 total
Holdings
  • Common Stock

    (indirect: By LLC)
    4,673,270
  • Common Stock

    (indirect: By Trust)
    170,000
  • Common Stock

    (indirect: By Trust)
    503,753
Footnotes (3)
  • [F1]Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
  • [F2]Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
  • [F3]Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.

Issuer

Intra-Cellular Therapies, Inc.

CIK 0001567514

Entity typeother

Related Parties

1
  • filerCIK 0001299430

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:11 PM ET
Size
7.7 KB